Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

Lake Success, New York

Phase 1 colorectal cancer trials in Lake Success, NY

12 Phase 1 colorectal cancer studies are recruiting participants at sites in Lake Success as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Lake Success at a glance

  • 12 studies are recruiting at a site in Lake Success.
  • By phase: Early Phase 1 (2), Phase 1 (5), Phase 1/2 (5).
  • By sponsor: industry (10), university, hospital or other (2).
  • Most recent update to one of these records: November 13, 2026.

Studies recruiting in Lake Success

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    START New York
    Registry record
    NCT07488676 · updated
  2. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Study site
    START New York Long Island LLC
    Registry record
    NCT06270706 · updated
  3. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    START New York Long Island, LLC
    Registry record
    NCT07503808 · updated
  4. EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Eikon Therapeutics
    Study site
    START New York-Long Island
    Registry record
    NCT07262619 · updated
  5. A Study of MGC030 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Study site
    START New York-Long Island
    Registry record
    NCT07822399 · updated
  6. A Study of MGC026 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Study site
    START-New York Long Island
    Registry record
    NCT06242470 · updated
  7. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Study site
    Northwell Health Cancer Institute
    Registry record
    NCT04657068 · updated
  8. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Northwell Health / RJ Zuckerberg Cancer Center
    Registry record
    NCT06445062 · updated
  9. A Study of IDP-001 in Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    InduPro, Inc.
    Study site
    START New York Long Island
    Registry record
    NCT07602842 · updated
  10. A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Coherus Oncology, Inc.
    Study site
    START New York
    Registry record
    NCT06657144 · updated
  11. Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

    • Early Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Northwell Health
    Study site
    RJ Zuckerberg
    Registry record
    NCT07193862 · updated
  12. INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases

    • Early Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Northwell Health
    Study site
    RJ Zuckerberg
    Registry record
    NCT07172282 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Lake Success, NY on ClinicalTrials.gov.

Ask about studies near Lake Success

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in New York

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call